Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by goregilon Sep 22, 2018 3:35pm

84 Views

Post# 28670983

Re re re few saw this coming

Present-Day Value From an Apple IPO Investment. As of August 2, 2018, Appleshares hit $207.05 per share making it the first company to cross $1 trillion in market cap. Currently, the initial investment of $990 would, at that price, be worth$521,740.80, not including dividends.Aug 2, 2018

Bullboard Posts

How one company is disrupting PoC testing